Citius pharmaceuticals, inc. reports fiscal second quarter 2025 financial results and provides business update

Cranford, n.j. , may 14, 2025 /prnewswire/ -- citius pharmaceuticals, inc. ("citius pharma" or the "company") (nasdaq: ctxr), a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products today reported business and financial results for the fiscal quarter ended march 31, 2025.

CTXR Ratings Summary

CTXR Quant Ranking